MullerMAckenheilM.Psychoneuroimunology and the cytokine action in the CNS: Implication for psychiatric disorders. Prog Neuropsychopharmacol Biol1998;22:1–33.
2.
StahlSM. Antidepressants and somatic symptoms: Therapeutic actions are expanding beyond affective spectrum disorders to functional somatic syndromes. J Clin Psychiatry2003;64:745–6.
3.
HaasHSSchauensteinKS. Neuroimmunomodulation via the limbic structures—the neuroanatomy of psychoimmunology. Prog Neurobiol1997;51:195–222.
4.
FabryZRaineCSHartMN. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS. Immunol Today1994;15:218–24.
5.
MaesM.Major depression and activation of the inflammatory response system. In: DantzerRWollmanEEYirmiyaR, editors. Cytokines, stress and depression, advances in experimental medicine and biology. Volume 461. New York: Kluwer Academic/Plenum Publishers; 1999. p 25–46.
6.
VisserJTJDe KloetERNagelkerkenL.Altered glucocorticoid regulation of the immune response in chronic fatigue syndrome. Ann NY Acad Sci2000;917:868–75.
7.
SzelenyiJSelmeczyZ.Immunomodulatory effect of antidepressants. Curr Opin Pharmacol2002:2;428–43.
8.
CapuronLDantzerR.Cytokines and depression: The need for a new paradigm. Brain Behav Immun2003;17(Suppl 1: S119–S124.).
